Financhill
Back

Revance Therapeutics Vs. Recursion Pharmaceuticals Industry Stock Comparison

Sell
10

RVNC
Revance Therapeutics

Last Price:
3.85
Seasonality Move:
2.15%
Sell
44

RXRX
Recursion Pharmaceuticals

Last Price:
5.80
Seasonality Move:
6.36%
Sell
10
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.84. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.75. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: 227722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.06 - 5.8) Sell
Bollinger Bands (100): (3.74 - 6.28) Sell

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -4487806 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.21 - 7.15) Sell
Bollinger Bands (100): (6.27 - 7.63) Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.03 Sell
20-day SMA: 4.84 Sell
50-day SMA: 5.22 Sell
200-day SMA: 4.61 Sell
8-day EMA: 4.07 Sell
20-day EMA: 4.56 Sell
50-day EMA: 4.97 Sell
200-day EMA: 6.03 Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.52 Sell
20-day SMA: 6.7 Sell
50-day SMA: 6.63 Sell
200-day SMA: 8.34 Sell
8-day EMA: 6.34 Sell
20-day EMA: 6.58 Sell
50-day EMA: 6.71 Sell
200-day EMA: 7.7 Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):